Literature DB >> 12900430

Elastase-induced suppression of endothelin-mediated Ca2+ entry mechanisms of vascular contraction.

David K W Chew1, Julia M Orshal, Raouf A Khalil.   

Abstract

Abdominal aortic aneurysm (AAA) is associated with increased endothelin (ET-1), both systemically and locally in the aorta. Also, elastase activity is increased in human AAA, and elastase perfusion of the aorta induces aneurysm formation in animal models of AAA. However, whether elastase directly affects the ET-1-induced mechanisms of aortic smooth muscle contraction is unclear. Isometric contraction and 45Ca2+ influx were measured in aortic strips isolated from male Sprague-Dawley rats and treated with elastase (5 U/mL). To avoid degradation of the extracellular matrix proteins by elastase, experiments were performed in the presence of elastin (10 mg/mL). In normal Krebs solution (2.5 mmol/L Ca2+), ET-1 (10(-7) mol/L) caused contraction of aortic strips that was inhibited by elastase (5 U/mL). The elastase-induced inhibition of ET-1 contraction was slow in onset (4.6+/-0.4 minutes), time-dependent, complete in 34+/-3 minutes, and reversible. In Ca2+-free Krebs solution, caffeine (25 mmol/L) caused a small contraction that was not inhibited by elastase, suggesting that elastase does not inhibit Ca2+ release from the intracellular stores. Membrane depolarization by 96 mmol/L KCl, which stimulates Ca2+ entry from the extracellular space, caused a contraction that was inhibited by elastase in a concentration-dependent, time-dependent, and reversible fashion. The reversible inhibitory effects of elastase, particularly in the presence of elastin, suggest that they are not due to dissolution of the extracellular matrix or smooth muscle contractile proteins. Elastase also inhibited ET-1 and KCl-induced 45Ca2+ influx. Thus, elastase directly inhibits ET-1-induced Ca2+ entry mechanisms of vascular smooth muscle contraction, which may explain the role of elastase and ET-1 during the development of AAA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900430     DOI: 10.1161/01.HYP.0000086200.93184.8E

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  The vascular endothelin system in hypertension--recent patents and discoveries.

Authors:  Meri M Hynynen; Raouf A Khalil
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2006-01

Review 2.  Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension.

Authors:  Raouf A Khalil
Journal:  Curr Mol Pharmacol       Date:  2011-11       Impact factor: 3.339

Review 3.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

Review 4.  O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

Authors:  Victor V Lima; Fernanda R Giachini; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-10       Impact factor: 3.619

5.  Identification of crucial genes in abdominal aortic aneurysm by WGCNA.

Authors:  Siliang Chen; Dan Yang; Chuxiang Lei; Yuan Li; Xiaoning Sun; Mengyin Chen; Xiao Wu; Yuehong Zheng
Journal:  PeerJ       Date:  2019-10-08       Impact factor: 2.984

6.  Identification of crucial genes mediating abdominal aortic aneurysm pathogenesis based on gene expression profiling of perivascular adipose tissue by WGCNA.

Authors:  Siliang Chen; Dan Yang; Bao Liu; Yuexin Chen; We Ye; Mengyin Chen; Yuehong Zheng
Journal:  Ann Transl Med       Date:  2021-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.